Evidence map›Paper›PMID 37290019›Full record

ArticleJCO global oncology2023

Reply to E.C. Dee et al.

Bogda Koczwara, Alexandre Chan, Michael Jefford, Wendy W T Lam, Carolyn Taylor, Claire E Wakefield, Nirmala Bhoo Pathy, Bishal Gyawali, Gregory Harvet, Yan Lou and 4 more

Abstract read
In one paragraph

Article in JCO global oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Bogda KoczwaraBogda Koczwara, MBioethics, Department of Medical Oncology, Flinders Medical Centre, College of Medicine and Public Health, Flinders University, Adelaide, Australia; Alexandre Chan, PharmD, MPH, School of Pharmacy and Pharmaceutical Sciences, University of California, Irvine, CA, Department of Oncology Pharmacy, National Cancer Centre Singapore, Singapore; Michael Jefford, MBBS, PhD, MPH, MHlthServMt, Department of Health Services Research and Australian Cancer Survivorship Centre, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia, Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia; Wendy W.T. Lam, MSc, Jockey Club Institute of Cancer Care, LKS Faculty of Medicine and Centre for Psycho-oncology Research and Training, School of Public Health, The University of Hong Kong, Hong Kong, China; Carolyn Taylor, BFA, Global Focus on Cancer, South Salem, NY; Claire E. Wakefield, PhD, MPH, School of Clinical Medicine, UNSW Medicine & Health, Discipline of Paediatrics and Child Health, Sydney, Australia, Behavioural Sciences Unit, Kids Cancer Centre, Sydney Children's Hospital, Randwick, Australia; Nirmala Bhoo Pathy, MD, PhD, Centre for Epidemiology and Evidence Based Practice, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia; Bishal Gyawali, MD, PhD, Queen's Global Oncology Program, Department of Oncology, Queen's University, Kingston, Canada; Gregory Harvet, MD, Department of Paediatrics, Centre Hospitalier Territorial, Noumea, New Caledonia; Yan Lou, PhD, RN, School of Nursing, Department of Medicine, Hangzhou Normal University, Hangzhou, Zhejiang Province, China; C.S. Pramesh MS, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India; Miyako Takahashi, MD, PhD, Japan Cancer Survivorship Network, Tokyo, Japan, Iwate Medical University, Iwate, Japan; Ke Yu, PhD, Tokyo Jikei University School of Medicine, Tokyo, Japan; and Raymond J. Chan, PhD, RN, Caring Futures Institute, College of Nursing and Health Sciences, Flinders University, Bedford Park, Australia.ORCID 0000-0002-1201-1642
Alexandre ChanBogda Koczwara, MBioethics, Department of Medical Oncology, Flinders Medical Centre, College of Medicine and Public Health, Flinders University, Adelaide, Australia; Alexandre Chan, PharmD, MPH, School of Pharmacy and Pharmaceutical Sciences, University of California, Irvine, CA, Department of Oncology Pharmacy, National Cancer Centre Singapore, Singapore; Michael Jefford, MBBS, PhD, MPH, MHlthServMt, Department of Health Services Research and Australian Cancer Survivorship Centre, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia, Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia; Wendy W.T. Lam, MSc, Jockey Club Institute of Cancer Care, LKS Faculty of Medicine and Centre for Psycho-oncology Research and Training, School of Public Health, The University of Hong Kong, Hong Kong, China; Carolyn Taylor, BFA, Global Focus on Cancer, South Salem, NY; Claire E. Wakefield, PhD, MPH, School of Clinical Medicine, UNSW Medicine & Health, Discipline of Paediatrics and Child Health, Sydney, Australia, Behavioural Sciences Unit, Kids Cancer Centre, Sydney Children's Hospital, Randwick, Australia; Nirmala Bhoo Pathy, MD, PhD, Centre for Epidemiology and Evidence Based Practice, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia; Bishal Gyawali, MD, PhD, Queen's Global Oncology Program, Department of Oncology, Queen's University, Kingston, Canada; Gregory Harvet, MD, Department of Paediatrics, Centre Hospitalier Territorial, Noumea, New Caledonia; Yan Lou, PhD, RN, School of Nursing, Department of Medicine, Hangzhou Normal University, Hangzhou, Zhejiang Province, China; C.S. Pramesh MS, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India; Miyako Takahashi, MD, PhD, Japan Cancer Survivorship Network, Tokyo, Japan, Iwate Medical University, Iwate, Japan; Ke Yu, PhD, Tokyo Jikei University School of Medicine, Tokyo, Japan; and Raymond J. Chan, PhD, RN, Caring Futures Institute, College of Nursing and Health Sciences, Flinders University, Bedford Park, Australia.ORCID 0000-0003-4391-4219
Michael JeffordBogda Koczwara, MBioethics, Department of Medical Oncology, Flinders Medical Centre, College of Medicine and Public Health, Flinders University, Adelaide, Australia; Alexandre Chan, PharmD, MPH, School of Pharmacy and Pharmaceutical Sciences, University of California, Irvine, CA, Department of Oncology Pharmacy, National Cancer Centre Singapore, Singapore; Michael Jefford, MBBS, PhD, MPH, MHlthServMt, Department of Health Services Research and Australian Cancer Survivorship Centre, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia, Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia; Wendy W.T. Lam, MSc, Jockey Club Institute of Cancer Care, LKS Faculty of Medicine and Centre for Psycho-oncology Research and Training, School of Public Health, The University of Hong Kong, Hong Kong, China; Carolyn Taylor, BFA, Global Focus on Cancer, South Salem, NY; Claire E. Wakefield, PhD, MPH, School of Clinical Medicine, UNSW Medicine & Health, Discipline of Paediatrics and Child Health, Sydney, Australia, Behavioural Sciences Unit, Kids Cancer Centre, Sydney Children's Hospital, Randwick, Australia; Nirmala Bhoo Pathy, MD, PhD, Centre for Epidemiology and Evidence Based Practice, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia; Bishal Gyawali, MD, PhD, Queen's Global Oncology Program, Department of Oncology, Queen's University, Kingston, Canada; Gregory Harvet, MD, Department of Paediatrics, Centre Hospitalier Territorial, Noumea, New Caledonia; Yan Lou, PhD, RN, School of Nursing, Department of Medicine, Hangzhou Normal University, Hangzhou, Zhejiang Province, China; C.S. Pramesh MS, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India; Miyako Takahashi, MD, PhD, Japan Cancer Survivorship Network, Tokyo, Japan, Iwate Medical University, Iwate, Japan; Ke Yu, PhD, Tokyo Jikei University School of Medicine, Tokyo, Japan; and Raymond J. Chan, PhD, RN, Caring Futures Institute, College of Nursing and Health Sciences, Flinders University, Bedford Park, Australia.ORCID 0000-0002-8792-7807
Wendy W T LamBogda Koczwara, MBioethics, Department of Medical Oncology, Flinders Medical Centre, College of Medicine and Public Health, Flinders University, Adelaide, Australia; Alexandre Chan, PharmD, MPH, School of Pharmacy and Pharmaceutical Sciences, University of California, Irvine, CA, Department of Oncology Pharmacy, National Cancer Centre Singapore, Singapore; Michael Jefford, MBBS, PhD, MPH, MHlthServMt, Department of Health Services Research and Australian Cancer Survivorship Centre, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia, Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia; Wendy W.T. Lam, MSc, Jockey Club Institute of Cancer Care, LKS Faculty of Medicine and Centre for Psycho-oncology Research and Training, School of Public Health, The University of Hong Kong, Hong Kong, China; Carolyn Taylor, BFA, Global Focus on Cancer, South Salem, NY; Claire E. Wakefield, PhD, MPH, School of Clinical Medicine, UNSW Medicine & Health, Discipline of Paediatrics and Child Health, Sydney, Australia, Behavioural Sciences Unit, Kids Cancer Centre, Sydney Children's Hospital, Randwick, Australia; Nirmala Bhoo Pathy, MD, PhD, Centre for Epidemiology and Evidence Based Practice, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia; Bishal Gyawali, MD, PhD, Queen's Global Oncology Program, Department of Oncology, Queen's University, Kingston, Canada; Gregory Harvet, MD, Department of Paediatrics, Centre Hospitalier Territorial, Noumea, New Caledonia; Yan Lou, PhD, RN, School of Nursing, Department of Medicine, Hangzhou Normal University, Hangzhou, Zhejiang Province, China; C.S. Pramesh MS, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India; Miyako Takahashi, MD, PhD, Japan Cancer Survivorship Network, Tokyo, Japan, Iwate Medical University, Iwate, Japan; Ke Yu, PhD, Tokyo Jikei University School of Medicine, Tokyo, Japan; and Raymond J. Chan, PhD, RN, Caring Futures Institute, College of Nursing and Health Sciences, Flinders University, Bedford Park, Australia.ORCID 0000-0003-2383-0149
Carolyn TaylorBogda Koczwara, MBioethics, Department of Medical Oncology, Flinders Medical Centre, College of Medicine and Public Health, Flinders University, Adelaide, Australia; Alexandre Chan, PharmD, MPH, School of Pharmacy and Pharmaceutical Sciences, University of California, Irvine, CA, Department of Oncology Pharmacy, National Cancer Centre Singapore, Singapore; Michael Jefford, MBBS, PhD, MPH, MHlthServMt, Department of Health Services Research and Australian Cancer Survivorship Centre, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia, Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia; Wendy W.T. Lam, MSc, Jockey Club Institute of Cancer Care, LKS Faculty of Medicine and Centre for Psycho-oncology Research and Training, School of Public Health, The University of Hong Kong, Hong Kong, China; Carolyn Taylor, BFA, Global Focus on Cancer, South Salem, NY; Claire E. Wakefield, PhD, MPH, School of Clinical Medicine, UNSW Medicine & Health, Discipline of Paediatrics and Child Health, Sydney, Australia, Behavioural Sciences Unit, Kids Cancer Centre, Sydney Children's Hospital, Randwick, Australia; Nirmala Bhoo Pathy, MD, PhD, Centre for Epidemiology and Evidence Based Practice, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia; Bishal Gyawali, MD, PhD, Queen's Global Oncology Program, Department of Oncology, Queen's University, Kingston, Canada; Gregory Harvet, MD, Department of Paediatrics, Centre Hospitalier Territorial, Noumea, New Caledonia; Yan Lou, PhD, RN, School of Nursing, Department of Medicine, Hangzhou Normal University, Hangzhou, Zhejiang Province, China; C.S. Pramesh MS, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India; Miyako Takahashi, MD, PhD, Japan Cancer Survivorship Network, Tokyo, Japan, Iwate Medical University, Iwate, Japan; Ke Yu, PhD, Tokyo Jikei University School of Medicine, Tokyo, Japan; and Raymond J. Chan, PhD, RN, Caring Futures Institute, College of Nursing and Health Sciences, Flinders University, Bedford Park, Australia.
Claire E WakefieldBogda Koczwara, MBioethics, Department of Medical Oncology, Flinders Medical Centre, College of Medicine and Public Health, Flinders University, Adelaide, Australia; Alexandre Chan, PharmD, MPH, School of Pharmacy and Pharmaceutical Sciences, University of California, Irvine, CA, Department of Oncology Pharmacy, National Cancer Centre Singapore, Singapore; Michael Jefford, MBBS, PhD, MPH, MHlthServMt, Department of Health Services Research and Australian Cancer Survivorship Centre, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia, Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia; Wendy W.T. Lam, MSc, Jockey Club Institute of Cancer Care, LKS Faculty of Medicine and Centre for Psycho-oncology Research and Training, School of Public Health, The University of Hong Kong, Hong Kong, China; Carolyn Taylor, BFA, Global Focus on Cancer, South Salem, NY; Claire E. Wakefield, PhD, MPH, School of Clinical Medicine, UNSW Medicine & Health, Discipline of Paediatrics and Child Health, Sydney, Australia, Behavioural Sciences Unit, Kids Cancer Centre, Sydney Children's Hospital, Randwick, Australia; Nirmala Bhoo Pathy, MD, PhD, Centre for Epidemiology and Evidence Based Practice, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia; Bishal Gyawali, MD, PhD, Queen's Global Oncology Program, Department of Oncology, Queen's University, Kingston, Canada; Gregory Harvet, MD, Department of Paediatrics, Centre Hospitalier Territorial, Noumea, New Caledonia; Yan Lou, PhD, RN, School of Nursing, Department of Medicine, Hangzhou Normal University, Hangzhou, Zhejiang Province, China; C.S. Pramesh MS, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India; Miyako Takahashi, MD, PhD, Japan Cancer Survivorship Network, Tokyo, Japan, Iwate Medical University, Iwate, Japan; Ke Yu, PhD, Tokyo Jikei University School of Medicine, Tokyo, Japan; and Raymond J. Chan, PhD, RN, Caring Futures Institute, College of Nursing and Health Sciences, Flinders University, Bedford Park, Australia.ORCID 0000-0001-7704-7067
Nirmala Bhoo PathyBogda Koczwara, MBioethics, Department of Medical Oncology, Flinders Medical Centre, College of Medicine and Public Health, Flinders University, Adelaide, Australia; Alexandre Chan, PharmD, MPH, School of Pharmacy and Pharmaceutical Sciences, University of California, Irvine, CA, Department of Oncology Pharmacy, National Cancer Centre Singapore, Singapore; Michael Jefford, MBBS, PhD, MPH, MHlthServMt, Department of Health Services Research and Australian Cancer Survivorship Centre, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia, Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia; Wendy W.T. Lam, MSc, Jockey Club Institute of Cancer Care, LKS Faculty of Medicine and Centre for Psycho-oncology Research and Training, School of Public Health, The University of Hong Kong, Hong Kong, China; Carolyn Taylor, BFA, Global Focus on Cancer, South Salem, NY; Claire E. Wakefield, PhD, MPH, School of Clinical Medicine, UNSW Medicine & Health, Discipline of Paediatrics and Child Health, Sydney, Australia, Behavioural Sciences Unit, Kids Cancer Centre, Sydney Children's Hospital, Randwick, Australia; Nirmala Bhoo Pathy, MD, PhD, Centre for Epidemiology and Evidence Based Practice, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia; Bishal Gyawali, MD, PhD, Queen's Global Oncology Program, Department of Oncology, Queen's University, Kingston, Canada; Gregory Harvet, MD, Department of Paediatrics, Centre Hospitalier Territorial, Noumea, New Caledonia; Yan Lou, PhD, RN, School of Nursing, Department of Medicine, Hangzhou Normal University, Hangzhou, Zhejiang Province, China; C.S. Pramesh MS, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India; Miyako Takahashi, MD, PhD, Japan Cancer Survivorship Network, Tokyo, Japan, Iwate Medical University, Iwate, Japan; Ke Yu, PhD, Tokyo Jikei University School of Medicine, Tokyo, Japan; and Raymond J. Chan, PhD, RN, Caring Futures Institute, College of Nursing and Health Sciences, Flinders University, Bedford Park, Australia.ORCID 0000-0003-0568-8863
Bishal GyawaliBogda Koczwara, MBioethics, Department of Medical Oncology, Flinders Medical Centre, College of Medicine and Public Health, Flinders University, Adelaide, Australia; Alexandre Chan, PharmD, MPH, School of Pharmacy and Pharmaceutical Sciences, University of California, Irvine, CA, Department of Oncology Pharmacy, National Cancer Centre Singapore, Singapore; Michael Jefford, MBBS, PhD, MPH, MHlthServMt, Department of Health Services Research and Australian Cancer Survivorship Centre, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia, Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia; Wendy W.T. Lam, MSc, Jockey Club Institute of Cancer Care, LKS Faculty of Medicine and Centre for Psycho-oncology Research and Training, School of Public Health, The University of Hong Kong, Hong Kong, China; Carolyn Taylor, BFA, Global Focus on Cancer, South Salem, NY; Claire E. Wakefield, PhD, MPH, School of Clinical Medicine, UNSW Medicine & Health, Discipline of Paediatrics and Child Health, Sydney, Australia, Behavioural Sciences Unit, Kids Cancer Centre, Sydney Children's Hospital, Randwick, Australia; Nirmala Bhoo Pathy, MD, PhD, Centre for Epidemiology and Evidence Based Practice, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia; Bishal Gyawali, MD, PhD, Queen's Global Oncology Program, Department of Oncology, Queen's University, Kingston, Canada; Gregory Harvet, MD, Department of Paediatrics, Centre Hospitalier Territorial, Noumea, New Caledonia; Yan Lou, PhD, RN, School of Nursing, Department of Medicine, Hangzhou Normal University, Hangzhou, Zhejiang Province, China; C.S. Pramesh MS, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India; Miyako Takahashi, MD, PhD, Japan Cancer Survivorship Network, Tokyo, Japan, Iwate Medical University, Iwate, Japan; Ke Yu, PhD, Tokyo Jikei University School of Medicine, Tokyo, Japan; and Raymond J. Chan, PhD, RN, Caring Futures Institute, College of Nursing and Health Sciences, Flinders University, Bedford Park, Australia.ORCID 0000-0001-7444-8594
Gregory HarvetBogda Koczwara, MBioethics, Department of Medical Oncology, Flinders Medical Centre, College of Medicine and Public Health, Flinders University, Adelaide, Australia; Alexandre Chan, PharmD, MPH, School of Pharmacy and Pharmaceutical Sciences, University of California, Irvine, CA, Department of Oncology Pharmacy, National Cancer Centre Singapore, Singapore; Michael Jefford, MBBS, PhD, MPH, MHlthServMt, Department of Health Services Research and Australian Cancer Survivorship Centre, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia, Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia; Wendy W.T. Lam, MSc, Jockey Club Institute of Cancer Care, LKS Faculty of Medicine and Centre for Psycho-oncology Research and Training, School of Public Health, The University of Hong Kong, Hong Kong, China; Carolyn Taylor, BFA, Global Focus on Cancer, South Salem, NY; Claire E. Wakefield, PhD, MPH, School of Clinical Medicine, UNSW Medicine & Health, Discipline of Paediatrics and Child Health, Sydney, Australia, Behavioural Sciences Unit, Kids Cancer Centre, Sydney Children's Hospital, Randwick, Australia; Nirmala Bhoo Pathy, MD, PhD, Centre for Epidemiology and Evidence Based Practice, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia; Bishal Gyawali, MD, PhD, Queen's Global Oncology Program, Department of Oncology, Queen's University, Kingston, Canada; Gregory Harvet, MD, Department of Paediatrics, Centre Hospitalier Territorial, Noumea, New Caledonia; Yan Lou, PhD, RN, School of Nursing, Department of Medicine, Hangzhou Normal University, Hangzhou, Zhejiang Province, China; C.S. Pramesh MS, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India; Miyako Takahashi, MD, PhD, Japan Cancer Survivorship Network, Tokyo, Japan, Iwate Medical University, Iwate, Japan; Ke Yu, PhD, Tokyo Jikei University School of Medicine, Tokyo, Japan; and Raymond J. Chan, PhD, RN, Caring Futures Institute, College of Nursing and Health Sciences, Flinders University, Bedford Park, Australia.ORCID 0000-0002-1959-6460
Yan LouBogda Koczwara, MBioethics, Department of Medical Oncology, Flinders Medical Centre, College of Medicine and Public Health, Flinders University, Adelaide, Australia; Alexandre Chan, PharmD, MPH, School of Pharmacy and Pharmaceutical Sciences, University of California, Irvine, CA, Department of Oncology Pharmacy, National Cancer Centre Singapore, Singapore; Michael Jefford, MBBS, PhD, MPH, MHlthServMt, Department of Health Services Research and Australian Cancer Survivorship Centre, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia, Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia; Wendy W.T. Lam, MSc, Jockey Club Institute of Cancer Care, LKS Faculty of Medicine and Centre for Psycho-oncology Research and Training, School of Public Health, The University of Hong Kong, Hong Kong, China; Carolyn Taylor, BFA, Global Focus on Cancer, South Salem, NY; Claire E. Wakefield, PhD, MPH, School of Clinical Medicine, UNSW Medicine & Health, Discipline of Paediatrics and Child Health, Sydney, Australia, Behavioural Sciences Unit, Kids Cancer Centre, Sydney Children's Hospital, Randwick, Australia; Nirmala Bhoo Pathy, MD, PhD, Centre for Epidemiology and Evidence Based Practice, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia; Bishal Gyawali, MD, PhD, Queen's Global Oncology Program, Department of Oncology, Queen's University, Kingston, Canada; Gregory Harvet, MD, Department of Paediatrics, Centre Hospitalier Territorial, Noumea, New Caledonia; Yan Lou, PhD, RN, School of Nursing, Department of Medicine, Hangzhou Normal University, Hangzhou, Zhejiang Province, China; C.S. Pramesh MS, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India; Miyako Takahashi, MD, PhD, Japan Cancer Survivorship Network, Tokyo, Japan, Iwate Medical University, Iwate, Japan; Ke Yu, PhD, Tokyo Jikei University School of Medicine, Tokyo, Japan; and Raymond J. Chan, PhD, RN, Caring Futures Institute, College of Nursing and Health Sciences, Flinders University, Bedford Park, Australia.ORCID 0000-0002-6844-1625
C S PrameshBogda Koczwara, MBioethics, Department of Medical Oncology, Flinders Medical Centre, College of Medicine and Public Health, Flinders University, Adelaide, Australia; Alexandre Chan, PharmD, MPH, School of Pharmacy and Pharmaceutical Sciences, University of California, Irvine, CA, Department of Oncology Pharmacy, National Cancer Centre Singapore, Singapore; Michael Jefford, MBBS, PhD, MPH, MHlthServMt, Department of Health Services Research and Australian Cancer Survivorship Centre, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia, Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia; Wendy W.T. Lam, MSc, Jockey Club Institute of Cancer Care, LKS Faculty of Medicine and Centre for Psycho-oncology Research and Training, School of Public Health, The University of Hong Kong, Hong Kong, China; Carolyn Taylor, BFA, Global Focus on Cancer, South Salem, NY; Claire E. Wakefield, PhD, MPH, School of Clinical Medicine, UNSW Medicine & Health, Discipline of Paediatrics and Child Health, Sydney, Australia, Behavioural Sciences Unit, Kids Cancer Centre, Sydney Children's Hospital, Randwick, Australia; Nirmala Bhoo Pathy, MD, PhD, Centre for Epidemiology and Evidence Based Practice, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia; Bishal Gyawali, MD, PhD, Queen's Global Oncology Program, Department of Oncology, Queen's University, Kingston, Canada; Gregory Harvet, MD, Department of Paediatrics, Centre Hospitalier Territorial, Noumea, New Caledonia; Yan Lou, PhD, RN, School of Nursing, Department of Medicine, Hangzhou Normal University, Hangzhou, Zhejiang Province, China; C.S. Pramesh MS, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India; Miyako Takahashi, MD, PhD, Japan Cancer Survivorship Network, Tokyo, Japan, Iwate Medical University, Iwate, Japan; Ke Yu, PhD, Tokyo Jikei University School of Medicine, Tokyo, Japan; and Raymond J. Chan, PhD, RN, Caring Futures Institute, College of Nursing and Health Sciences, Flinders University, Bedford Park, Australia.ORCID 0000-0002-3635-0083
Miyako TakahashiBogda Koczwara, MBioethics, Department of Medical Oncology, Flinders Medical Centre, College of Medicine and Public Health, Flinders University, Adelaide, Australia; Alexandre Chan, PharmD, MPH, School of Pharmacy and Pharmaceutical Sciences, University of California, Irvine, CA, Department of Oncology Pharmacy, National Cancer Centre Singapore, Singapore; Michael Jefford, MBBS, PhD, MPH, MHlthServMt, Department of Health Services Research and Australian Cancer Survivorship Centre, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia, Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia; Wendy W.T. Lam, MSc, Jockey Club Institute of Cancer Care, LKS Faculty of Medicine and Centre for Psycho-oncology Research and Training, School of Public Health, The University of Hong Kong, Hong Kong, China; Carolyn Taylor, BFA, Global Focus on Cancer, South Salem, NY; Claire E. Wakefield, PhD, MPH, School of Clinical Medicine, UNSW Medicine & Health, Discipline of Paediatrics and Child Health, Sydney, Australia, Behavioural Sciences Unit, Kids Cancer Centre, Sydney Children's Hospital, Randwick, Australia; Nirmala Bhoo Pathy, MD, PhD, Centre for Epidemiology and Evidence Based Practice, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia; Bishal Gyawali, MD, PhD, Queen's Global Oncology Program, Department of Oncology, Queen's University, Kingston, Canada; Gregory Harvet, MD, Department of Paediatrics, Centre Hospitalier Territorial, Noumea, New Caledonia; Yan Lou, PhD, RN, School of Nursing, Department of Medicine, Hangzhou Normal University, Hangzhou, Zhejiang Province, China; C.S. Pramesh MS, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India; Miyako Takahashi, MD, PhD, Japan Cancer Survivorship Network, Tokyo, Japan, Iwate Medical University, Iwate, Japan; Ke Yu, PhD, Tokyo Jikei University School of Medicine, Tokyo, Japan; and Raymond J. Chan, PhD, RN, Caring Futures Institute, College of Nursing and Health Sciences, Flinders University, Bedford Park, Australia.ORCID 0000-0002-1740-5093
Ke YuBogda Koczwara, MBioethics, Department of Medical Oncology, Flinders Medical Centre, College of Medicine and Public Health, Flinders University, Adelaide, Australia; Alexandre Chan, PharmD, MPH, School of Pharmacy and Pharmaceutical Sciences, University of California, Irvine, CA, Department of Oncology Pharmacy, National Cancer Centre Singapore, Singapore; Michael Jefford, MBBS, PhD, MPH, MHlthServMt, Department of Health Services Research and Australian Cancer Survivorship Centre, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia, Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia; Wendy W.T. Lam, MSc, Jockey Club Institute of Cancer Care, LKS Faculty of Medicine and Centre for Psycho-oncology Research and Training, School of Public Health, The University of Hong Kong, Hong Kong, China; Carolyn Taylor, BFA, Global Focus on Cancer, South Salem, NY; Claire E. Wakefield, PhD, MPH, School of Clinical Medicine, UNSW Medicine & Health, Discipline of Paediatrics and Child Health, Sydney, Australia, Behavioural Sciences Unit, Kids Cancer Centre, Sydney Children's Hospital, Randwick, Australia; Nirmala Bhoo Pathy, MD, PhD, Centre for Epidemiology and Evidence Based Practice, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia; Bishal Gyawali, MD, PhD, Queen's Global Oncology Program, Department of Oncology, Queen's University, Kingston, Canada; Gregory Harvet, MD, Department of Paediatrics, Centre Hospitalier Territorial, Noumea, New Caledonia; Yan Lou, PhD, RN, School of Nursing, Department of Medicine, Hangzhou Normal University, Hangzhou, Zhejiang Province, China; C.S. Pramesh MS, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India; Miyako Takahashi, MD, PhD, Japan Cancer Survivorship Network, Tokyo, Japan, Iwate Medical University, Iwate, Japan; Ke Yu, PhD, Tokyo Jikei University School of Medicine, Tokyo, Japan; and Raymond J. Chan, PhD, RN, Caring Futures Institute, College of Nursing and Health Sciences, Flinders University, Bedford Park, Australia.ORCID 0000-0001-7587-3015
Raymond J ChanBogda Koczwara, MBioethics, Department of Medical Oncology, Flinders Medical Centre, College of Medicine and Public Health, Flinders University, Adelaide, Australia; Alexandre Chan, PharmD, MPH, School of Pharmacy and Pharmaceutical Sciences, University of California, Irvine, CA, Department of Oncology Pharmacy, National Cancer Centre Singapore, Singapore; Michael Jefford, MBBS, PhD, MPH, MHlthServMt, Department of Health Services Research and Australian Cancer Survivorship Centre, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia, Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia; Wendy W.T. Lam, MSc, Jockey Club Institute of Cancer Care, LKS Faculty of Medicine and Centre for Psycho-oncology Research and Training, School of Public Health, The University of Hong Kong, Hong Kong, China; Carolyn Taylor, BFA, Global Focus on Cancer, South Salem, NY; Claire E. Wakefield, PhD, MPH, School of Clinical Medicine, UNSW Medicine & Health, Discipline of Paediatrics and Child Health, Sydney, Australia, Behavioural Sciences Unit, Kids Cancer Centre, Sydney Children's Hospital, Randwick, Australia; Nirmala Bhoo Pathy, MD, PhD, Centre for Epidemiology and Evidence Based Practice, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia; Bishal Gyawali, MD, PhD, Queen's Global Oncology Program, Department of Oncology, Queen's University, Kingston, Canada; Gregory Harvet, MD, Department of Paediatrics, Centre Hospitalier Territorial, Noumea, New Caledonia; Yan Lou, PhD, RN, School of Nursing, Department of Medicine, Hangzhou Normal University, Hangzhou, Zhejiang Province, China; C.S. Pramesh MS, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India; Miyako Takahashi, MD, PhD, Japan Cancer Survivorship Network, Tokyo, Japan, Iwate Medical University, Iwate, Japan; Ke Yu, PhD, Tokyo Jikei University School of Medicine, Tokyo, Japan; and Raymond J. Chan, PhD, RN, Caring Futures Institute, College of Nursing and Health Sciences, Flinders University, Bedford Park, Australia.ORCID 0000-0003-0248-7046

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID37290019
PMCPMC10497264

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.